AmerisourceBergen Corp. disclosed in its latest quarterly report on Form 10-Q filed with the U.S. Securities and Exchange Commission that the trial date for the fourth amended qui tam complaint involving the company has been moved from July 2011 to…
AmerisourceBergen Corp. disclosed in its latest quarterly on Form 10-Q filed with the U.S. Securities and Exchange Commission that it will continue to prosecute its claim for unpaid invoices and counterclaims asserted by Rx USA International, Inc.
In 2001, the Company…
AmerisourceBergen Corp. disclosed in its latest quarterly on Form 10-Q filed with the U.S. Securities and Exchange Commission that the Superior Court of the State of California, County of Orange has scheduled for Feb. 23, 2009, a hearing on motion…
AmerisourceBergen Corp. disclosed in its latest Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission that as a result of the March 2008 settlement between the company, ASD Specialty Healthcare, Inc. and Massachusetts Biologic Laboratories, it…
AmerisourceBergen Corp. disclosed in its latest Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission that the investigation by the Office of the Attorney General of the State of New York into the company’s potential liabilities…
AmerisourceBergen Corp. disclosed in its latest Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission that on Oct. 31, 2008, the Review Official on a former Bergen Brunswig chief executive officer’s appeal issued an interim decision…
AmerisourceBergen Corp. disclosed in its latest Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission that U.S. District Court for the Eastern District of New York has scheduled the trial on its lawsuit against RxUSA International,…